
PGY-3 @LaheyMedicine | 🇪🇬
Burlington, MA
Joined December 2021
- Tweets154
- Following4.1K
- Followers888
- Likes17.4K
3 years of @ACPIMPhysicians Doctor’s Dilemma! Grateful to represent @bethisraellahey with the best teams!
2
22
1,790
Ghada Mohamed retweeted
Until now, physicians using AI in clinic had to assemble the patient’s context themselves. Allergies, comorbidities, medications, prior procedures, copy-pasted in from the chart.
Today we’re announcing a partnership with @CedarsSinai. OpenEvidence now works directly inside Epic, drawing on the patient’s full record and interpreting the medical literature through the lens of that specific patient.
Cedars-Sinai is the first academic health system to deploy patient-aware clinical intelligence at enterprise scale. The clinician asks a complex question in natural language. The answer reflects both the best available evidence and the patient in front of them.
Patient data is never stored after the clinical session or used for any other purpose.
Had a great time presenting our work at @DDWMeeting in Chicago and reconnecting with residents, fellows, and mentors!
Happy to share our review paper on pancreatic cancer screening in press in @Gastro_Clinics! @SriGaddamMD @MalakMunirMD @AmarRai_23
Read here: sciencedirect.com/science/ar…
Grateful for the opportunity to present my research at #ACG2024 and for my first outstanding poster presenter! Grateful for the mentorship and guidance of @SriGaddamMD.
Ghada Mohamed retweeted
Thrilled to share our findings on early-stage pancreatic cancer staging, published on @JAMA_current: lymph nodes often missed on preop imaging with huge impact on treatment and survival - @SriGaddamMD @GhadaMMD_ @CedarsSinai
This study found that 78% of patients with stage I pancreatic ductal adenocarcinoma (PDAC) and 29% with stage II PDAC with initial stages designated on preoperative imaging were upstaged on histopathology. ja.ma/4cWq5Zo
Ghada Mohamed retweeted
Our paper in @AnnalsofIM on rapidly changing trends in GLP-1RA use
- Use has dramatically increased since 2011 particularly after 2020
- Use in obesity without diabetes has tripled
- Off-label use has increased from from 0.21% in 2019 to 0.37% in 2023
- Semaglutide (Ozempic, Wegovy) rose from 31% of prescriptions to 88% from 2019 to 2023
- Although men, African Americans, and Hispanics generally have higher rates of diabetes and obesity, they are disproportionately prescribed fewer GLP1 meds
acpjournals.org/doi/10.7326/…
Ghada Mohamed retweeted
Well, that's a first!
Our paper's imaginative illustration of "carrot trachea with steak lungs on a plate" made it to the cover of the Gastroenterology journal!
📣 Our July issue is now online! Click the link to take a look inside 📖 ow.ly/tmu250SoeMz
#IssueRelease #NewIssue
Happy to see our research recognized by @CedarsSinaiMed! Excited to share more about our work @DDWMeeting!
9
2,175
Check out our paper on the use of GLP1-RAs prior to elective endoscopy. Honored to be part of the team!
Should GLP1-RAs (e.g. Ozempic) be stopped prior to elective endoscopic procedures?
YES!
Our study in @AGA_Gastro shows GLP1-RAs increase the risk of aspiration pneumonia after endoscopy by 33%
gastrojournal.org/article/S0…
Happy to have our research recognized as a presidential poster at #ACG2023. All thanks to Danting Jiang, Dr. @hjillianh, Dr. Matthew Kelly, and Dr. Neil Surana. Special thanks to Dr. @jatinroper for leading this project. Read more here: cdmcd.co/KpE3P5
1
4
1,527
My first (hopefully out of many) @videogie article! All thanks to @EndoTx and @a_gilman.
Cholangioscopic recanalization of a completely obstructed anastomotic ... sciencedirect.com/science/ar…
Ghada Mohamed retweeted
The answers for this week are out! Check out the tweetorial on Mirizzi syndrome made by @ghmm47 and me along with @AdvaniRashmiMD
Time to head over to @CrushingGIBoard now!
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Anderson .Paak & The Free Nationals: NPR Music Tiny Desk Concert youtu.be/ferZnZ0_rSM
1
1,746
Check out our new paper on the utility and use of fecal biomarkers in monitoring Crohn’s disease and discriminating activity.
Was a pleasure working on this with @Jonathansegal85 and collaborators!
mdpi.com/2227-9059/11/5/1408


























